Evidence map›Paper›PMID 35853927›Full record

ArticleScientific reports2022

Examining the COVID-19 case growth rate due to visitor vs. local mobility in the United States using machine learning.

Satya Katragadda, Ravi Teja Bhupatiraju, Vijay Raghavan, Ziad Ashkar, Raju Gottumukkala

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Networked Time Series Imputation via Position-aware Graph Enhanced Variational Autoencoders.KDD : proceedings. International Conference on Knowledge Discovery & Data Mining · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Satya KatragaddaInformatics Research Institute, University of Louisiana at Lafayette, Lafayette, USA.
Ravi Teja BhupatirajuInformatics Research Institute, University of Louisiana at Lafayette, Lafayette, USA.
Vijay RaghavanInformatics Research Institute, University of Louisiana at Lafayette, Lafayette, USA.
Ziad AshkarInformatics Research Institute, University of Louisiana at Lafayette, Lafayette, USA.
Raju GottumukkalaInformatics Research Institute, University of Louisiana at Lafayette, Lafayette, USA. raju.gottumukkala@louisiana.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Travel patterns and mobility affect the spread of infectious diseases like COVID-19. However, we do not know to what extent local vs. visitor mobility affects the growth in the number of cases. This study evaluates the impact of state-level local vs. visitor mobility in understanding the growth with respect to the number of cases for COVID spread in the United States between March 1, 2020, and December 31, 2020. Two metrics, namely local and visitor transmission risk, were extracted from mobility data to capture the transmission potential of COVID-19 through mobility. A combination of the three factors: the current number of cases, local transmission risk, and the visitor transmission risk, are used to model the future number of cases using various machine learning models. The factors that contribute to better forecast performance are the ones that impact the number of cases. The statistical significance of the forecasts is also evaluated using the Diebold-Mariano test. Finally, the performance of models is compared for three waves across all 50 states. The results show that visitor mobility significantly impacts the case growth by improving the prediction accuracy by 33.78%. We also observe that the impact of visitor mobility is more pronounced during the first peak, i.e., March-June 2020.

Indexed as

COVID-19ForecastingHumansMachine LearningSARS-CoV-2TravelUnited States

Identifiers

PMID35853927
PMCPMC9296469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.